Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

Description

The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication. The study will evaluate and monitor use of ReX in respect of: * treatment duration * adverse events * patient adherence and compliance * engagement with ReX via patient-reported outcomes Patients participating in the study will receive their normal medication as standard of care via ReX. Progress will be monitored via patients' responses to questions presented on the ReX touch screen.

Conditions

Any Solid Oral Medication

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication. The study will evaluate and monitor use of ReX in respect of: * treatment duration * adverse events * patient adherence and compliance * engagement with ReX via patient-reported outcomes Patients participating in the study will receive their normal medication as standard of care via ReX. Progress will be monitored via patients' responses to questions presented on the ReX touch screen.

Non-randomized Observational Study to Collate Data Regarding the Safety, Efficacy and Satisfaction of ReX® in the Management of Solid Oral Medications.

Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

Condition
Any Solid Oral Medication
Intervention / Treatment

-

Contacts and Locations

Cincinnati

OHC, Cincinnati, Ohio, United States, 45242

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. 18 years of age or older.
  • 2. Care team recommends the use of ReX as a standard of care.
  • 3. Patients have 5th grade reading level.
  • 4. Patient was prescribed oral medication.
  • 5. Patient takes medication at home.
  • 1. Patient has significant physical disability including poor fine motor skills, impaired visual or auditory faculties, mental disorders or other impairment affecting ability to provide Informed Consent or use the ReX dispensing unit effectively.
  • 2. Patient failed to pass the learning module during ReX onboarding flow.
  • 3. Patient is at end stage or terminal illness with anticipated life expectancy of 6 months or less.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dosentrx Ltd.,

David Waterhouse, MD, PRINCIPAL_INVESTIGATOR, US Oncology

Study Record Dates

2026-01-31